MIRZA ZIAD 4
4 · INNOVUS PHARMACEUTICALS, INC. · Filed Feb 27, 2018
Insider Transaction Report
Form 4
MIRZA ZIAD
Director
Transactions
- Award
Restricted Stock Units
2018-02-23$0.08/sh+35,928$3,000→ 1,718,158 totalFrom: 2018-02-23Exp: 2028-02-23→ Common Stock (35,928 underlying) - Award
Restricted Stock Units
2018-02-23$0.18/sh+500,000$89,500→ 2,218,158 totalExp: 2028-02-23→ Common Stock (500,000 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock.
- [F2]The Reporting Person was granted a Restricted Stock Unit on February 23, 2018 of 35,928 shares, which were fully vested on the date of the grant. The RSU is for the Reporting Person's quarterly compensation as a member of the Board of Directors for the fourth quarter of 2017 and was valued on December 31, 2017 in accordance with the approved compensation plan for the non-employee members of the Board of Directors.
- [F3]These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2016 Equity Incentive Plan.
- [F4]RSU was granted on February 23, 2018. 125,000 RSUs vest on February 23, 2019; the total remaining shares vest in eight (8) pro rata equal installments, quarterly for two (2) years thereafter, subject to continued service.